|
HY-B0075-500mg
|
MedChemexpress LLC
|
Melatonin [CAS 73-31-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-B0075-1mL
|
MedChemexpress LLC
|
Melatonin [CAS 73-31-4] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-B0075S1-10mg
|
MedChemexpress LLC
|
Melatonin-d3 [CAS 90735-69-6]
|
|
|
|
|
HY-B0075S1-100mg
|
MedChemexpress LLC
|
Melatonin-d3 [CAS 90735-69-6]
|
|
|
|
|
HY-B0075S1-25mg
|
MedChemexpress LLC
|
Melatonin-d3 [CAS 90735-69-6]
|
|
|
|
|
HY-B0075S1-5mg
|
MedChemexpress LLC
|
Melatonin-d3 [CAS 90735-69-6]
|
|
|
|
|
HY-B0075S1-50mg
|
MedChemexpress LLC
|
Melatonin-d3 [CAS 90735-69-6]
|
|
|
|
|
HY-B0075S2-1mg
|
MedChemexpress LLC
|
Melatonin-d7 [CAS 615251-68-8]
|
|
|
|
|
HY-N1434-10g
|
MedChemexpress LLC
|
Methyl p-coumarate [CAS 3943-97-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1434-5g
|
MedChemexpress LLC
|
Methyl p-coumarate [CAS 3943-97-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1434-1mL
|
MedChemexpress LLC
|
Methyl p-coumarate [CAS 3943-97-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-16322-10mg
|
MedChemexpress LLC
|
Minodronic acid [CAS 180064-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-16322-100mg
|
MedChemexpress LLC
|
Minodronic acid [CAS 180064-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-16322-5mg
|
MedChemexpress LLC
|
Minodronic acid [CAS 180064-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-16322-50mg
|
MedChemexpress LLC
|
Minodronic acid [CAS 180064-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-16322-1mL
|
MedChemexpress LLC
|
Minodronic acid [CAS 180064-38-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-K1060-100T
|
MedChemexpress LLC
|
Mitochondria Isolation Kit for Cultured Cells
|
|
|
|
|
HY-P99033-1mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99033-5mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|
